BRIEF published on 03/12/2026 at 07:30, 10 days 11 hours ago Closure of pharmaceutical production at Bichsel Pharmaceutical Production Galenica AG Social Plan Bichsel Closure Customer Transition
BRIEF published on 03/12/2026 at 07:30, 10 days 11 hours ago Galenica's Bichsel to Close Pharmaceutical Operations Customer Support Social Plan Bichsel Closure Job Redundancies Galenica Strategy
PRESS RELEASE published on 03/12/2026 at 07:25, 10 days 11 hours ago Consultation process at Bichsel completed Bichsel completes consultation process, to close pharmaceutical manufacturing operations with reduced job redundancies. Galenica's subsidiary to focus on home care services Galenica Pharmaceutical Manufacturing Consultation Process Redundancies Bichsel
BRIEF published on 03/10/2026 at 06:45, 12 days 12 hours ago Galenica records solid growth in 2025 and adjusts its forecasts EBIT Growth Diagnosis Galenica Pharmacies
BRIEF published on 03/10/2026 at 06:45, 12 days 12 hours ago Galenica Reports Strong 2025 Results and Raises Mid-Term Guidance Sales Growth EBIT Increase Healthcare Services Galenica Results Diagnostics Expansion
PRESS RELEASE published on 03/10/2026 at 06:40, 12 days 12 hours ago Galenica achieves strong annual result and increases mid-term guidance Galenica achieves strong annual results, increasing sales by 5.5% to CHF 4,135.6 million in 2025. Mid-term EBIT guidance raised to CHF 270 million by 2027 Sales Increase Annual Results EBIT Growth Galenica Mid-term Guidance
BRIEF published on 02/24/2026 at 06:45, 26 days 12 hours ago Galenica Restructures Bichsel with Focus on Home Care Services Home Care Services Galenica AG Bichsel Restructuring Job Impact Financial Effects
BRIEF published on 02/24/2026 at 06:45, 26 days 12 hours ago Galenica is repositioning its subsidiary Bichsel towards home healthcare Home Care Galenica Social Plan Bichsel Production Closed
PRESS RELEASE published on 02/24/2026 at 06:40, 26 days 12 hours ago Galenica focuses Bichsel’s business on home care services Galenica's subsidiary Bichsel to focus on home care services and discontinue pharmaceutical production by end of 2026, affecting 170 jobs. Galenica strengthens strategy implementation Galenica Pharmaceutical Production Home Care Services Strategy Implementation Bichsel
BRIEF published on 01/22/2026 at 06:45, 2 months ago Galenica AG Sees Record Sales Growth to Over CHF 4 Billion Financial Performance Sales Growth Galenica Pharmacy Expansion Diagnostics Introduction
Published on 03/20/2026 at 13:30, 2 days 5 hours ago Unusual Machines Announces Pricing of Approximately $150 Million Public Offering of Common Stock
Published on 03/20/2026 at 12:30, 2 days 6 hours ago CANEX Metals Announces the Numbers of Gold Basin Shares Taken up by Canex Metals
Published on 03/22/2026 at 12:23, 6 hours 59 minutes ago Borussia Dortmund and Sebastian Kehl are ending their collaboration with immediate effect
Published on 03/20/2026 at 22:45, 1 day 20 hours ago Investor Alert: Berger Montague (Canada) PC represents investors that purchased shares of Super Micro Computer, Inc. listed on the CBOE Canada and elsewhere
Published on 03/20/2026 at 21:05, 1 day 22 hours ago Fractal EMS Receives ISO/IEC 9001 and 27001 Certifications
Published on 03/20/2026 at 21:05, 1 day 22 hours ago Nebius Group announces closing of private offering of convertible senior notes, with aggregate gross proceeds of approximately $4.3 billion
Published on 03/20/2026 at 19:00, 2 days ago AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 18:15, 2 days 1 hour ago Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 16:57, 2 days 2 hours ago Number of shares and voting rights - February 2026 (In French only)
Published on 03/19/2026 at 18:00, 3 days 1 hour ago Filing of the 2025 Universal Registration Document
